Matches 1 - 12 out of 12
Match Document Document Title
US20090291945 CYSTEINE PROTEASE INHIBITORS  
To provide a compound having an excellent cysteine protease inhibitory effect, and to provide a drug for treatment or prevention of the disease selected from the group consisting of osteoporosis,...
US20090203681 NOVEL N-(2-AMINO-PHENYL)-AMIDE DERIVATIVES  
The present invention provides novel compounds of the general formula (I) and pharmaceutically acceptable salts thereof, processes for the manufacture of these novel compounds and medicaments...
US20090181943 Inhibitors of Histone Deacetylase  
This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of formula compounds of the Formula (I) and N-oxides,...
US20080306054 Pharmaceutical Compounds  
The invention provides a compound for use as an inhibitor of Hsp90, the compound having the formula (I): or salts, tautomers, solvates and N-oxides thereof; wherein R 1 is hydroxy or hydrogen;...
US20080255105 Biphenyl Derivatives and Their Use in Treating Hepatitis C  
A compound which is a biphenyl derivative of formula (I), or a pharmaceutically acceptable salt thereof wherein: R 1 is a C 1 -C 6 alkyl group or a moiety -A 1 , -L 1 -A 1 , -A 1 -A 1 ′, -L 1...
US20080194536 Cyanoarylamines  
The present invention relates to a compound represented by the following formula: (I) or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, or a...
US20080176838 Dpp-IV Inhibitors  
The invention relates to compounds of formula (I) wherein R 1-9 , Z, n, X, A, and R b have the meaning as cited in the description and the claims. Said compounds are useful as DPP-IV...
US20080113976 N-ALKYLATED DIAMINOPROPANE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY  
The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis,...
US20080108595 INHIBITORS OF CATHEPSIN S  
The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at...
US20080090782 Materials and methods to potentiate cancer treatment  
Compounds that inhibit DNA-dependent protein kinase, compositions comprising the compounds, methods to inhibit the DNA-PK biological activity, methods to sensitize cells the agents that cause DNA...
US20080064687 Novel thiourea derivatives and the pharmaceutical compositions containing the same  
The present invention relates to novel thiourea derivatives as a modulator for vanilloid receptor (VR) and the pharmaceutical compositions containing the same. As diseases associated with the...
US20080004258 BUTYL AND BUTYNYL BENZYL AMINE COMPOUNDS  
Certain substituted butyl and butynyl benzyl amine compounds are histamine H 3 receptor and/or serotonin transporter modulators useful in the treatment of histamine H 3 receptor- and/or...
Matches 1 - 12 out of 12